Tumor Genomic Testing: Identifying Characteristics Associated With Germline Risk for Developing Malignancy
- Resource Type
- Authors
- Suzanne M. Mahon
- Source
- Clinical Journal of Oncology Nursing. 24:623-626
- Subject
- Cancer prevention
medicine.diagnostic_test
business.industry
Genetic counseling
Genetic Counseling
Genomics
Malignancy
medicine.disease
Bioinformatics
Germline
Germ Cells
Neoplasms
medicine
Humans
General Earth and Planetary Sciences
Genetic Testing
Personalized medicine
Family history
business
Germ-Line Mutation
Selection (genetic algorithm)
General Environmental Science
Genetic testing
- Language
- ISSN
- 1538-067X
1092-1095
Tumor genomic testing is used primarily to facilitate the selection of the best possible treatment for a malignancy based on the genomic characteristics of the tumor. Germline genomic testing has implications for care and recommendations for cancer prevention and early detection for the patient and their family. Careful review of specific components of tumor genomic testing reports and of the family history of malignancy can help ensure that families with potential germline risk are identified and referred for genetic counseling and genetic testing.